The role of hypertension in retinal blood flow alterations in open-angle glaucoma patients

Lauren Ciulla; Alon Harris; June Geng; Colin Ip; Patrick Serrano; Joshua Gross; Brent Siesky

doi:10.1111/aos.13365

The role of hypertension in retinal blood flow alterations in open-angle glaucoma patients

Lauren Ciulla
, Alon Harris
, June Geng
, Colin Ip
, Patrick Serrano
, Joshua Gross
, Brent Siesky

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	e794-e795
Journal	Acta Ophthalmologica
Volume	95
Issue number	8
DOIs	https://doi.org/10.1111/aos.13365
State	Published - Dec 2017
Externally published	Yes

Access to Document

10.1111/aos.13365

Cite this

@article{adf0ecb94b1d493d94c86d09b68a6390,

title = "The role of hypertension in retinal blood flow alterations in open-angle glaucoma patients",

author = "Lauren Ciulla and Alon Harris and June Geng and Colin Ip and Patrick Serrano and Joshua Gross and Brent Siesky",

note = "Funding Information: This study was supported in part by an unrestricted grant from Research to Prevent Blindness, New York, New York. Funding: Research was supported by Research to Prevent Blindness, NYC, NY. There are no conflict of interests. Dr. Alon Harris would like to disclose that he receives remuneration from Stemnion, Biolight, Nano Retina, AdOM, Science Based Health, Isarna Therapeutics and Ono Pharmaceuticals for serving as a consultant. Dr. Harris also holds an ownership interest in AdOM, Nano Retina and Oxymap. All relationships listed above are pursuant to Indiana University's policy on outside activities.",

year = "2017",

month = dec,

doi = "10.1111/aos.13365",

language = "English",

volume = "95",

pages = "e794--e795",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - The role of hypertension in retinal blood flow alterations in open-angle glaucoma patients

AU - Ciulla, Lauren

AU - Harris, Alon

AU - Geng, June

AU - Ip, Colin

AU - Serrano, Patrick

AU - Gross, Joshua

AU - Siesky, Brent

N1 - Funding Information: This study was supported in part by an unrestricted grant from Research to Prevent Blindness, New York, New York. Funding: Research was supported by Research to Prevent Blindness, NYC, NY. There are no conflict of interests. Dr. Alon Harris would like to disclose that he receives remuneration from Stemnion, Biolight, Nano Retina, AdOM, Science Based Health, Isarna Therapeutics and Ono Pharmaceuticals for serving as a consultant. Dr. Harris also holds an ownership interest in AdOM, Nano Retina and Oxymap. All relationships listed above are pursuant to Indiana University's policy on outside activities.

PY - 2017/12

Y1 - 2017/12

UR - https://www.scopus.com/pages/publications/85009776417

U2 - 10.1111/aos.13365

DO - 10.1111/aos.13365

M3 - Letter

C2 - 28084046

AN - SCOPUS:85009776417

SN - 1755-375X

VL - 95

SP - e794-e795

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

IS - 8

ER -